TRACON Pharmaceutical (TCON) Misses Q1 EPS by 127c

TRACON Pharmaceutical (NASDAQ: TCON) reported Q1 EPS of ($1.33), $1.27 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $100 thousand.

For earnings history and earnings-related data on TRACON Pharmaceutical (TCON) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
• The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue